Trial Profile

The Effect of Multiple Doses of Itraconazole on the Single-dose Pharmacokinetics of BI 3031185 Following Oral Administration in Healthy Trial Participants (an Open-label, Two-period, Fixed- Sequence Design Study)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 09 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BI 3031185 (Primary) ; Itraconazole
Indications Attention-deficit hyperactivity disorder; Borderline personality disorders
Focus Pharmacokinetics
Sponsors Boehringer Ingelheim; Boehringer Ingelheim GmbH International

04 Feb 2026 Status changed from active, no longer recruiting to completed.
21 Jan 2026 Planned End Date changed from 16 Jan 2026 to 21 Jan 2026.
21 Jan 2026 Planned primary completion date changed from 16 Jan 2026 to 21 Jan 2026.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com